American Psychosocial Oncology Society

Latest Content

Please check back later for more content.

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Oncology Recap: Approvals, Designations, and Decisions in September 2026

Plinabulin Receives FDA Fast Track Designation in Post-ICI NSCLC

Denosumab Biosimilar Approved For Existing Oncology Indications

CEPHEUS and Frontline Treatment in Newly Diagnosed Multiple Myeloma

New Drug Application Filed for Savolitinib/Osimertinib in MET+ NSCLC